Colgate Announces 2nd Quarter 2020 Results
- Net sales increased 1.0%, Organic sales* increased 5.5%
- GAAP EPS grew 9% to
$0.74 , Base Business EPS* grew 3% to$0.74 - GAAP Gross profit margin increased 110 basis points to 60.8%, Base Business Gross profit margin* increased 120 basis points to 60.8%
- Net cash provided by operations was
$1,794 million - Colgate’s leadership in toothpaste continued with its global market share at 40.0% year to date
- Colgate’s leadership in manual toothbrushes continued with its global market share at 31.0% year to date
- The Company is not providing 2020 financial guidance due to the continued uncertainty surrounding the business impacts from COVID-19 and related macroeconomic volatility
Second Quarter Total Company Results (GAAP) |
|||
($ in millions except per share amounts) |
2020 |
2019 |
Change |
|
|
|
+1.0% |
EPS (diluted) |
|
|
+9% |
|
|
|
|
|
|
|
|
Second Quarter Total Company Results (Base Business - Non-GAAP)* |
|||
($ in millions except per share amounts) |
2020 |
2019 |
Change |
Organic Sales Growth |
+5.5% |
||
Base Business EPS (diluted) |
|
|
+3% |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
“While net sales growth was significantly impacted by foreign exchange, the 5.5% organic sales growth reflected a good balance of positive volume and higher pricing on a worldwide basis and was led by strong growth in
“We continue to see elevated demand across our geographies in certain categories such as liquid hand soap, dish liquid, bar soap and cleaners. In other categories, we are starting to see the impact of consumers working down their pantry inventories, particularly in
"The gross margin expansion in the quarter allowed us to invest behind our brands. Over the second half of the year, we will continue to fund strong consumer programs to drive our business.
“Looking ahead, we continue to expect a mid-single digit negative impact on net sales for the year from foreign exchange, based on current spot rates. Given the continued uncertainty related to the impact of the virus and government actions to stem the virus, including macroeconomic impacts, we have decided not to reinstate our financial guidance for 2020 at this time. As we proceed through this pandemic we plan to reinstate our guidance when we have the visibility to forecast our results with more confidence.”
Divisional Performance
The following are comments about divisional performance for second quarter 2020 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.
Second Quarter Sales Growth By Division (% change 2Q 2020 vs. 2Q 2019) |
||||||
|
Net |
Organic |
As Reported |
Organic |
Pricing |
FX |
|
+12.0% |
+11.0% |
+13.0% |
+11.5% |
-0.5% |
-0.5% |
|
-13.5% |
+4.5% |
-4.5% |
-4.5% |
+9.0% |
-18.0% |
|
+5.0% |
-1.5% |
+7.5% |
-1.5% |
—% |
-2.5% |
|
-3.0% |
+0.5% |
-3.0% |
-3.0% |
+3.5% |
-3.5% |
|
-6.0% |
+2.5% |
+0.5% |
-1.5% |
+4.0% |
-10.5% |
Hill's |
+9.5% |
+11.5% |
+7.5% |
+7.5% |
+4.0% |
-2.0% |
|
|
|
|
|
|
|
|
+1.0% |
+5.5% |
+3.5% |
+2.0% |
+3.5% |
-6.0% |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.
The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in |
Second Quarter Operating Profit By Division ($ in millions) |
||||
|
2Q 2020 |
% Change vs 2Q 2019 |
% to Net Sales |
Change in basis points vs 2Q 2019 % to |
|
|
—% |
26.8% |
-320 |
|
|
-9% |
28.4% |
+140 |
|
|
7% |
25.6% |
+40 |
|
|
1% |
28.2% |
+130 |
|
|
19% |
24.5% |
+520 |
Hill's |
|
14% |
28.4% |
+110 |
|
|
|
|
|
|
|
7.0% |
24.3% |
+130 |
|
|
1.9% |
24.3% |
+30 |
*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures. |
- Organic sales growth was driven by
the United States andCanada . - In
the United States , Colgate's share of the toothpaste market is 34.9% year to date and its share of the manual toothbrush market is 40.9% year to date. - The decrease in Operating profit as a percentage of Net sales was primarily due to increased advertising investment, unfavorable mix, higher overhead expenses, primarily driven by higher logistics costs, and higher raw and packaging material costs, partially offset by cost savings from the Company’s funding-the-growth initiatives.
- Organic sales growth in
Argentina ,Brazil , theCaribbean region andColombia was partially offset by an organic sales decline inMexico . - The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, higher pricing and lower overhead costs, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs.
- Organic sales declines in the
United Kingdom ,Germany andSpain were partially offset by organic sales growth inSwitzerland andBelgium . - The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, favorable mix and decreased advertising investment, partially offset by higher overhead expenses, higher raw and packaging material costs, which included foreign exchange transaction costs, and amortization expense related to the Filorga skin health acquisition.
- Organic sales growth in the
Greater China region andAustralia was partially offset by organic sales declines inThailand andIndia . - The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, cost savings from the Company's funding-the-growth initiatives and decreased advertising investment, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs, and higher overhead expenses.
- Organic sales growth was led by
Turkey , theSaudi Arabia /Gulf States region andSouth Africa . - The increase in Operating profit as a percentage of Net sales was primarily due to decreased advertising investment, cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by higher overhead expenses and higher raw and packaging material costs, which included foreign exchange transaction costs.
- Organic sales growth was led by
the United States andEurope . - The increase in Operating profit as a percentage of Net sales was primarily due to lower overhead expenses, cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by increased advertising investment and higher raw and packaging material costs.
Webcast Information
At
About
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking statements (as that term is defined in the
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and/or the related webcast, which may not be the same as or comparable to similar measures presented by other companies:
- Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges resulting from the Global Growth and Efficiency Program, acquisition-related costs and a benefit related to a recent reorganization of the ownership structure of certain foreign subsidiaries and a new operating structure being implemented within one of the Company's divisions.
- Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
- Free cash flow before dividends: Net cash provided by operations less Capital expenditures.
This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and six months ended
Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, repurchase stock, pay dividends and fund future business opportunities, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the six months ended
(See attached tables for second quarter results.)
Table 1 |
||||||||
|
||||||||
|
||||||||
Condensed Consolidated Statements of Income |
||||||||
|
||||||||
For the Three Months Ended |
||||||||
|
||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||
|
||||||||
|
2020 |
2019 |
||||||
|
|
|
||||||
Net sales |
$ |
3,897 |
|
$ |
3,866 |
|
||
|
|
|
||||||
Cost of sales |
|
1,528 |
|
|
1,558 |
|
||
|
|
|
||||||
Gross profit |
|
2,369 |
|
|
2,308 |
|
||
|
|
|
||||||
Gross profit margin |
|
60.8 |
% |
|
59.7 |
% |
||
|
|
|
||||||
Selling, general and administrative expenses |
|
1,395 |
|
|
1,369 |
|
||
|
|
|
||||||
Other (income) expense, net |
|
28 |
|
|
51 |
|
||
|
|
|
||||||
Operating profit |
|
946 |
|
|
888 |
|
||
|
|
|
||||||
Operating profit margin |
|
24.3 |
% |
|
23.0 |
% |
||
|
|
|
||||||
Non-service related postretirement costs |
|
20 |
|
|
27 |
|
||
|
|
|
||||||
Interest (income) expense, net |
|
35 |
|
|
38 |
|
||
|
|
|
||||||
Income before income taxes |
|
891 |
|
|
823 |
|
||
|
|
|
||||||
Provision for income taxes |
|
216 |
|
|
205 |
|
||
|
|
|
||||||
Effective tax rate |
|
24.2 |
% |
|
24.9 |
% |
||
|
|
|
||||||
Net income including noncontrolling interests |
|
675 |
|
|
618 |
|
||
|
|
|
||||||
Less: Net income attributable to noncontrolling interests |
|
40 |
|
|
32 |
|
||
|
|
|
||||||
Net income attributable to |
$ |
635 |
|
$ |
586 |
|
||
|
|
|
||||||
Earnings per common share |
|
|
||||||
Basic |
$ |
0.74 |
|
$ |
0.68 |
|
||
Diluted |
$ |
0.74 |
|
$ |
0.68 |
|
||
|
|
|
||||||
Supplemental Income Statement Information |
|
|
||||||
Average common shares outstanding |
|
|
||||||
Basic |
|
857.4 |
|
|
859.4 |
|
||
Diluted |
|
858.9 |
|
|
861.9 |
|
||
|
|
|
||||||
Advertising |
$ |
439 |
|
$ |
416 |
|
Table 2 |
||||||||
|
||||||||
|
||||||||
Condensed Consolidated Statements of Income |
||||||||
|
||||||||
For the Six Months Ended |
||||||||
|
||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||
|
||||||||
|
2020 |
2019 |
||||||
|
|
|
||||||
Net sales |
$ |
7,994 |
|
$ |
7,750 |
|
||
|
|
|
||||||
Cost of sales |
3,160 |
|
3,155 |
|
||||
|
|
|
||||||
Gross profit |
4,834 |
|
4,595 |
|
||||
|
|
|
||||||
Gross profit margin |
|
60.5 |
% |
|
59.3 |
% |
||
|
|
|
||||||
Selling, general and administrative expenses |
|
2,868 |
|
2,734 |
|
|||
|
|
|
||||||
Other (income) expense, net |
|
68 |
|
94 |
|
|||
|
|
|
||||||
Operating profit |
|
1,898 |
|
1,767 |
|
|||
|
|
|
||||||
Operating profit margin |
|
23.7 |
% |
|
22.8 |
% |
||
|
|
|
||||||
Non-service related postretirement costs |
|
41 |
|
52 |
|
|||
|
|
|
||||||
Interest (income) expense, net |
|
71 |
|
78 |
|
|||
|
|
|
||||||
Income before income taxes |
|
1,786 |
|
1,637 |
|
|||
|
|
|
||||||
Provision for income taxes |
|
363 |
|
419 |
|
|||
|
|
|
||||||
Effective tax rate |
|
20.3 |
% |
|
25.6 |
% |
||
|
|
|
||||||
Net income including noncontrolling interests |
|
1,423 |
|
1,218 |
|
|||
|
|
|
||||||
Less: Net income attributable to noncontrolling interests |
|
73 |
|
72 |
|
|||
|
|
|
||||||
Net income attributable to |
$ |
1,350 |
|
$ |
1,146 |
|
||
|
|
|
||||||
Earnings per common share |
|
|
||||||
Basic(1) |
$ |
1.58 |
|
$ |
1.33 |
|
||
Diluted(1) |
$ |
1.57 |
|
$ |
1.33 |
|
||
|
|
|
||||||
Supplemental Income Statement Information |
|
|
||||||
Average common shares outstanding |
|
|
||||||
Basic |
|
857.1 |
|
|
860.7 |
|
||
Diluted |
|
858.6 |
|
|
862.7 |
|
||
|
|
|
||||||
Advertising |
$ |
923 |
|
$ |
845 |
|
Note:
(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.
Table 3 |
||||||||||||
|
||||||||||||
|
||||||||||||
Condensed Consolidated Balance Sheets |
||||||||||||
|
||||||||||||
As of |
||||||||||||
|
||||||||||||
(Dollars in Millions) (Unaudited) |
||||||||||||
|
|
|
|
|||||||||
|
|
|
|
|
|
|||||||
|
2020 |
|
2019 |
|
2019 |
|||||||
Cash and cash equivalents |
$ |
997 |
|
$ |
883 |
|
$ |
863 |
|
|||
Receivables, net |
|
1,231 |
|
|
1,440 |
|
|
1,590 |
|
|||
Inventories |
|
1,524 |
|
|
1,400 |
|
|
1,322 |
|
|||
Other current assets |
|
460 |
|
|
456 |
|
|
480 |
|
|||
Property, plant and equipment, net |
|
3,483 |
|
|
3,750 |
|
|
3,793 |
|
|||
|
|
3,628 |
|
|
3,508 |
|
|
2,536 |
|
|||
Other intangible assets, net |
|
2,787 |
|
|
2,667 |
|
|
1,609 |
|
|||
Other assets |
|
1,031 |
|
|
930 |
|
|
958 |
|
|||
Total assets |
$ |
15,141 |
|
$ |
15,034 |
|
$ |
13,151 |
|
|||
|
|
|
|
|||||||||
Total debt |
$ |
7,392 |
|
$ |
7,847 |
|
$ |
6,645 |
|
|||
Other current liabilities |
|
4,072 |
|
|
3,524 |
|
|
3,777 |
|
|||
Other non-current liabilities |
|
2,945 |
|
|
3,105 |
|
|
2,739 |
|
|||
Total liabilities |
|
14,409 |
|
|
14,476 |
|
|
13,161 |
|
|||
|
|
268 |
|
|
117 |
|
|
(347 |
) |
|||
Noncontrolling interests |
|
464 |
|
|
441 |
|
|
337 |
|
|||
Total liabilities and equity |
$ |
15,141 |
|
$ |
15,034 |
|
$ |
13,151 |
|
|||
|
|
|
|
|||||||||
Supplemental Balance Sheet Information |
|
|
|
|||||||||
Debt less cash, cash equivalents and marketable securities(1) |
$ |
6,370 |
|
$ |
6,941 |
|
$ |
5,716 |
|
|||
Working capital % of sales |
|
(5.5 |
)% |
|
(1.6 |
)% |
|
(2.9 |
)% |
Note:
(1) Marketable securities of
Table 4 |
||||||||
|
||||||||
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
|
||||||||
For the Six Months Ended |
||||||||
|
||||||||
(Dollars in Millions) (Unaudited) |
||||||||
|
|
|
||||||
|
2020 |
2019 |
||||||
Operating Activities |
|
|
||||||
Net income including noncontrolling interests |
$ |
1,423 |
|
$ |
1,218 |
|
||
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations: |
|
|||||||
Depreciation and amortization |
|
266 |
|
|
256 |
|
||
Restructuring and termination benefits, net of cash |
|
(35 |
) |
|
21 |
|
||
Stock-based compensation expense |
|
32 |
|
|
34 |
|
||
Deferred income taxes |
|
(147 |
) |
|
53 |
|
||
Voluntary benefit plan contributions |
|
— |
|
|
(102 |
) |
||
Cash effects of changes in: |
|
|
||||||
Receivables |
|
121 |
|
|
(178 |
) |
||
Inventories |
|
(176 |
) |
|
(63 |
) |
||
Accounts payable and other accruals |
|
347 |
|
|
(14 |
) |
||
Other non-current assets and liabilities |
|
(37 |
) |
|
24 |
|
||
Net cash provided by operations |
|
1,794 |
|
|
1,249 |
|
||
|
|
|
||||||
Investing Activities |
|
|
||||||
Capital expenditures |
|
(159 |
) |
|
(146 |
) |
||
Purchases of marketable securities and investments |
|
(48 |
) |
|
(80 |
) |
||
Proceeds from sale of marketable securities and investments |
|
42 |
|
|
14 |
|
||
Payment for acquisitions, net of cash acquired |
|
(352 |
) |
|
— |
|
||
Net cash used in investing activities |
|
(517 |
) |
|
(212 |
) |
||
|
|
|
||||||
Financing Activities |
|
|
||||||
Principal payments on debt |
|
(2,102 |
) |
|
(3,105 |
) |
||
Proceeds from issuance of debt |
|
1,620 |
|
|
3,368 |
|
||
Dividends paid |
|
(784 |
) |
|
(770 |
) |
||
Purchases of treasury shares |
|
(228 |
) |
|
(664 |
) |
||
Proceeds from exercise of stock options |
|
353 |
|
|
267 |
|
||
Net cash provided by (used in) financing activities |
|
(1,141 |
) |
|
(904 |
) |
||
|
|
|
||||||
Effect of exchange rate changes on Cash and cash equivalents |
|
(22 |
) |
|
4 |
|
||
Net increase (decrease) in Cash and cash equivalents |
|
114 |
|
|
137 |
|
||
Cash and cash equivalents at beginning of the period |
|
883 |
|
|
726 |
|
||
Cash and cash equivalents at end of the period |
$ |
997 |
|
$ |
863 |
|
||
|
|
|
||||||
Supplemental Cash Flow Information |
|
|
||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) |
|
|
||||||
Net cash provided by operations |
$ |
1,794 |
|
$ |
1,249 |
|
||
Less: Capital expenditures |
|
(159 |
) |
|
(146 |
) |
||
Free cash flow before dividends |
$ |
1,635 |
|
$ |
1,103 |
|
||
|
|
|
||||||
|
|
|
||||||
Income taxes paid |
$ |
349 |
|
$ |
463 |
|
Table 5 |
||||||||||||||||
|
||||||||||||||||
|
|
|
||||||||||||||
Segment Information |
||||||||||||||||
|
|
|
||||||||||||||
For the Three and Six Months Ended |
||||||||||||||||
|
|
|
||||||||||||||
(Dollars in Millions) (Unaudited) |
||||||||||||||||
|
|
|
|
|||||||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||||||
|
2020 |
2019 |
2020 |
2019 |
||||||||||||
|
|
|
|
|
||||||||||||
Oral, Personal and Home Care |
|
|
|
|
||||||||||||
|
|
|
|
|
||||||||||||
|
$ |
949 |
|
$ |
846 |
|
$ |
1,878 |
|
$ |
1,699 |
|
||||
|
|
805 |
|
|
929 |
|
|
1,694 |
|
|
1,818 |
|
||||
|
|
617 |
|
|
588 |
|
|
1,292 |
|
|
1,190 |
|
||||
|
|
625 |
|
|
646 |
|
|
1,258 |
|
|
1,346 |
|
||||
|
|
229 |
|
|
244 |
|
|
481 |
|
|
484 |
|
||||
|
|
|
|
|
||||||||||||
Total Oral, Personal and Home Care |
|
3,225 |
|
|
3,253 |
|
|
6,603 |
|
|
6,537 |
|
||||
|
|
|
|
|
||||||||||||
Pet Nutrition |
|
672 |
|
|
613 |
|
|
1,391 |
|
|
1,213 |
|
||||
|
|
|
|
|
||||||||||||
Total |
$ |
3,897 |
|
$ |
3,866 |
|
$ |
7,994 |
|
$ |
7,750 |
|
||||
|
|
|
|
|
||||||||||||
|
|
|
|
|
||||||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||||||
|
2020 |
2019 |
2020 |
2019 |
||||||||||||
Operating Profit |
|
|
|
|
||||||||||||
Oral, Personal and Home Care |
|
|
|
|
||||||||||||
|
|
|
|
|
||||||||||||
|
$ |
254 |
|
$ |
254 |
|
$ |
512 |
|
$ |
503 |
|
||||
|
|
229 |
|
|
251 |
|
|
478 |
|
|
483 |
|
||||
|
|
158 |
|
|
148 |
|
|
312 |
|
|
299 |
|
||||
|
|
176 |
|
|
174 |
|
|
337 |
|
|
363 |
|
||||
|
|
56 |
|
|
47 |
|
|
112 |
|
|
93 |
|
||||
|
|
|
|
|
||||||||||||
Total Oral, Personal and Home Care |
|
873 |
|
|
874 |
|
|
1,751 |
|
|
1,741 |
|
||||
|
|
|
|
|
||||||||||||
Pet Nutrition |
|
191 |
|
|
167 |
|
|
393 |
|
|
331 |
|
||||
Corporate(1) |
|
(118 |
) |
|
(153 |
) |
|
(246 |
) |
|
(305 |
) |
||||
|
|
|
|
|
||||||||||||
Total Operating Profit |
$ |
946 |
|
$ |
888 |
|
$ |
1,898 |
|
$ |
1,767 |
|
Note:
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended
Corporate Operating profit (loss) for the six months ended
Table 6 |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
Geographic Sales Analysis Percentage Changes |
||||||||||||||||||
|
||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||
|
||||||||||||||||||
(Unaudited) |
||||||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
COMPONENTS OF SALES CHANGE |
|||||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
Pricing |
|
||||||||||||
|
|
|
|
|
Coupons |
|
||||||||||||
|
Sales |
|
|
|
Consumer & |
|
||||||||||||
|
Change |
Organic |
As Reported |
Organic |
Trade |
Foreign |
||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||
|
1.0 |
% |
5.5 |
% |
3.5 |
% |
2.0 |
% |
3.5 |
% |
(6.0 |
)% |
||||||
|
12.0 |
% |
11.0 |
% |
13.0 |
% |
11.5 |
% |
(0.5 |
)% |
(0.5 |
)% |
||||||
|
(13.5 |
)% |
4.5 |
% |
(4.5 |
)% |
(4.5 |
)% |
9.0 |
% |
(18.0 |
)% |
||||||
|
5.0 |
% |
(1.5 |
)% |
7.5 |
% |
(1.5 |
)% |
— |
% |
(2.5 |
)% |
||||||
|
(3.0 |
)% |
0.5 |
% |
(3.0 |
)% |
(3.0 |
)% |
3.5 |
% |
(3.5 |
)% |
||||||
|
(6.0 |
)% |
2.5 |
% |
0.5 |
% |
(1.5 |
)% |
4.0 |
% |
(10.5 |
)% |
||||||
|
|
|
|
|
|
|
||||||||||||
Total CP Products(1) |
(1.0 |
)% |
4.0 |
% |
2.5 |
% |
0.5 |
% |
3.5 |
% |
(7.0 |
)% |
||||||
Hill’s |
9.5 |
% |
11.5 |
% |
7.5 |
% |
7.5 |
% |
4.0 |
% |
(2.0 |
)% |
||||||
Emerging Markets(2) |
(9.0 |
)% |
2.5 |
% |
(3.5 |
)% |
(4.0 |
)% |
6.5 |
% |
(12.0 |
)% |
||||||
Developed Markets(2) |
10.0 |
% |
8.0 |
% |
10.0 |
% |
7.0 |
% |
1.0 |
% |
(1.0 |
)% |
Notes:
(1) The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in
(2) Emerging Markets include
Table 7 |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
Geographic Sales Analysis Percentage Changes |
||||||||||||||||||
|
||||||||||||||||||
For the Six Months Ended |
||||||||||||||||||
|
||||||||||||||||||
(Unaudited) |
||||||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
|
|||||||||||||||
|
|
|
COMPONENTS OF SALES CHANGE |
|||||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
Pricing |
|
||||||||||||
|
|
|
|
|
Coupons |
|
||||||||||||
|
Sales |
|
|
|
Consumer & |
|
||||||||||||
|
Change |
Organic |
As Reported |
Organic |
Trade |
Foreign |
||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||
|
3.0 |
% |
6.5 |
% |
5.5 |
% |
4.0 |
% |
2.5 |
% |
(5.0 |
)% |
||||||
|
10.5 |
% |
9.5 |
% |
11.0 |
% |
9.5 |
% |
— |
% |
(0.5 |
)% |
||||||
|
(7.0 |
)% |
7.5 |
% |
(0.5 |
)% |
(0.5 |
)% |
8.0 |
% |
(14.5 |
)% |
||||||
|
8.5 |
% |
2.5 |
% |
12.0 |
% |
3.5 |
% |
(1.0 |
)% |
(2.5 |
)% |
||||||
|
(6.5 |
)% |
(3.5 |
)% |
(6.0 |
)% |
(6.0 |
)% |
2.5 |
% |
(3.0 |
)% |
||||||
|
(0.5 |
)% |
5.0 |
% |
5.5 |
% |
3.5 |
% |
1.5 |
% |
(7.5 |
)% |
||||||
Total CP Products(1) |
1.0 |
% |
4.5 |
% |
4.0 |
% |
2.0 |
% |
2.5 |
% |
(5.5 |
)% |
||||||
Hill’s |
14.5 |
% |
16.0 |
% |
12.0 |
% |
12.0 |
% |
4.0 |
% |
(1.5 |
)% |
||||||
Emerging Markets(2) |
(6.0 |
)% |
2.5 |
% |
(2.0 |
)% |
(2.5 |
)% |
5.0 |
% |
(9.0 |
)% |
||||||
Developed Markets(2) |
12.0 |
% |
10.0 |
% |
12.0 |
% |
9.0 |
% |
1.0 |
% |
(1.0 |
)% |
Notes:
(1) The impact of the previously disclosed acquisitions of the Filorga skin health business, the new joint venture in
(2) Emerging Markets include
Table 8 |
|||||||||||
|
|||||||||||
|
|||||||||||
Non-GAAP Reconciliations |
|||||||||||
|
|||||||||||
For the Three Months Ended |
|||||||||||
|
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||||
|
|
|
|
||||||||
Gross Profit |
2020 |
2019 |
|
||||||||
Gross profit, GAAP |
$ |
2,369 |
|
$ |
2,308 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(3 |
) |
|
||||
Gross profit, non-GAAP |
$ |
2,369 |
|
$ |
2,305 |
|
|
||||
|
|
|
|
||||||||
|
|
|
|
||||||||
Gross Profit Margin |
2020 |
2019 |
Change |
||||||||
Gross profit margin, GAAP |
|
60.8 |
% |
|
59.7 |
% |
110 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
(0.1 |
)% |
|
||||
Gross profit margin, non-GAAP |
|
60.8 |
% |
|
59.6 |
% |
120 |
|
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Selling, General and Administrative Expenses |
2020 |
2019 |
|
||||||||
Selling, general and administrative expenses, GAAP |
$ |
1,395 |
|
$ |
1,369 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(10 |
) |
|
||||
Selling, general and administrative expenses, non-GAAP |
$ |
1,395 |
|
$ |
1,359 |
|
|
||||
|
|
|
|
||||||||
Selling, General and Administrative Expenses as a Percentage of |
2020 |
2019 |
Change |
||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP |
|
35.8 |
% |
|
35.4 |
% |
40 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
(0.2 |
)% |
|
||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP |
|
35.8 |
% |
|
35.2 |
% |
60 |
|
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Other (Income) Expense, Net |
2020 |
2019 |
|
||||||||
Other (income) expense, net, GAAP |
$ |
28 |
|
$ |
51 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(33 |
) |
|
||||
Other (income) expense, net, non-GAAP |
$ |
28 |
|
$ |
18 |
|
|
||||
|
|
|
|
||||||||
|
|
|
|
||||||||
Operating Profit |
2020 |
2019 |
% Change |
||||||||
Operating profit, GAAP |
$ |
946 |
|
$ |
888 |
|
7 |
% |
|||
Global Growth and Efficiency Program |
|
— |
|
|
40 |
|
|
||||
Operating profit, non-GAAP |
$ |
946 |
|
$ |
928 |
|
2 |
% |
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Operating Profit Margin |
2020 |
2019 |
Change |
||||||||
Operating profit margin, GAAP |
|
24.3 |
% |
|
23.0 |
% |
130 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
1.0 |
% |
|
||||
Operating profit margin, non-GAAP |
|
24.3 |
% |
|
24.0 |
% |
30 |
|
|||
|
|||||||||||
|
|||||||||||
Non-Service Related Postretirement Costs |
2020 |
2019 |
|
||||||||
Non-service related postretirement costs, GAAP |
$ |
20 |
|
$ |
27 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(2 |
) |
|
||||
Non-service related postretirement costs, non-GAAP |
$ |
20 |
|
$ |
25 |
|
|
Table 8 |
||||||||||||||||||
Continued |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
Non-GAAP Reconciliations |
||||||||||||||||||
|
||||||||||||||||||
For the Three Months Ended |
||||||||||||||||||
|
||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
||||||||||||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
|
2020 |
|||||||||||||||||
|
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
||||||||||||
As Reported GAAP |
$ |
891 |
$ |
216 |
$ |
675 |
$ |
635 |
24.2 |
% |
$ |
0.74 |
||||||
Non-GAAP |
$ |
891 |
$ |
216 |
$ |
675 |
$ |
635 |
24.2 |
% |
$ |
0.74 |
||||||
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
||||||||||||
|
2019 |
|||||||||||||||||
|
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
||||||||||||
As Reported GAAP |
$ |
823 |
$ |
205 |
$ |
618 |
$ |
586 |
24.9 |
% |
$ |
0.68 |
||||||
Global Growth and Efficiency Program |
|
42 |
|
11 |
|
31 |
|
31 |
0.1 |
% |
|
0.04 |
||||||
Non-GAAP |
$ |
865 |
$ |
216 |
$ |
649 |
$ |
617 |
25.0 |
% |
$ |
0.72 |
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
Table 9 |
|||||||||||
|
|||||||||||
|
|||||||||||
Non-GAAP Reconciliations |
|||||||||||
|
|||||||||||
For the Six Months Ended |
|||||||||||
|
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||||
|
|
|
|
||||||||
Gross Profit |
2020 |
2019 |
|
||||||||
Gross profit, GAAP |
$ |
4,834 |
|
$ |
4,595 |
|
|
||||
Acquisition-related costs |
|
4 |
|
|
— |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
8 |
|
|
||||
Gross profit, non-GAAP |
$ |
4,838 |
|
$ |
4,603 |
|
|
||||
|
|
|
|
||||||||
|
|
|
|
||||||||
Gross Profit Margin |
2020 |
2019 |
Change |
||||||||
Gross profit margin, GAAP |
|
60.5 |
% |
|
59.3 |
% |
120 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
0.1 |
% |
|
||||
Gross profit margin, non-GAAP |
|
60.5 |
% |
|
59.4 |
% |
110 |
|
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Selling, General and Administrative Expenses |
2020 |
2019 |
|
||||||||
Selling, general and administrative expenses, GAAP |
$ |
2,868 |
|
$ |
2,734 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(14 |
) |
|
||||
Selling, general and administrative expenses, non-GAAP |
$ |
2,868 |
|
$ |
2,720 |
|
|
||||
|
|
|
|
||||||||
Selling, General and Administrative Expenses as a Percentage of |
2020 |
2019 |
Change |
||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP |
|
35.9 |
% |
|
35.3 |
% |
60 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
(0.2 |
)% |
|
||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP |
|
35.9 |
% |
|
35.1 |
% |
80 |
|
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Other (Income) Expense, Net |
2020 |
2019 |
|
||||||||
Other (income) expense, net, GAAP |
$ |
68 |
|
$ |
94 |
|
|
||||
Acquisition-related costs |
|
(2 |
) |
|
— |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(46 |
) |
|
||||
Other (income) expense, net, non-GAAP |
$ |
66 |
|
$ |
48 |
|
|
||||
|
|
|
|
||||||||
|
|
|
|
||||||||
Operating Profit |
2020 |
2019 |
% Change |
||||||||
Operating profit, GAAP |
$ |
1,898 |
|
$ |
1,767 |
|
7 |
% |
|||
Acquisition-related costs |
|
6 |
|
|
— |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
68 |
|
|
||||
Operating profit, non-GAAP |
$ |
1,904 |
|
$ |
1,835 |
|
4 |
% |
|||
|
|
|
|
||||||||
|
|
|
|
||||||||
Operating Profit Margin |
2020 |
2019 |
Change |
||||||||
Operating profit margin, GAAP |
|
23.7 |
% |
|
22.8 |
% |
90 |
|
|||
Global Growth and Efficiency Program |
|
— |
% |
|
0.9 |
% |
|
||||
Operating profit margin, non-GAAP |
|
23.8 |
% |
|
23.7 |
% |
10 |
|
|||
|
|||||||||||
|
|||||||||||
Non-Service Related Postretirement Costs |
2020 |
2019 |
|
||||||||
Non-service related postretirement costs, GAAP |
$ |
41 |
|
$ |
52 |
|
|
||||
Global Growth and Efficiency Program |
|
— |
|
|
(3 |
) |
|
||||
Non-service related postretirement costs, non-GAAP |
$ |
41 |
|
$ |
49 |
|
|
Table 9 |
|||||||||||||||||||||
Continued |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
Non-GAAP Reconciliations |
|||||||||||||||||||||
|
|||||||||||||||||||||
For the Six Months Ended |
|||||||||||||||||||||
|
|||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) |
|||||||||||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
2020 |
||||||||||||||||||||
|
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
|||||||||||||||
As Reported GAAP |
$ |
1,786 |
$ |
363 |
$ |
1,423 |
|
$ |
1,350 |
|
20.3 |
% |
$ |
1.57 |
|
||||||
Subsidiary and operating structure initiatives |
|
— |
|
71 |
|
(71 |
) |
|
(71 |
) |
4 |
% |
|
(0.08 |
) |
||||||
Acquisition-related costs |
|
6 |
|
2 |
|
4 |
|
|
4 |
|
— |
% |
|
— |
|
||||||
Non-GAAP |
$ |
1,792 |
$ |
436 |
$ |
1,356 |
|
$ |
1,283 |
|
24.3 |
% |
$ |
1.49 |
|
||||||
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||
|
2019 |
||||||||||||||||||||
|
Income Before Income Taxes |
Provision For Income Taxes(1) |
Net Income Including Noncontrolling Interests |
Net Income Attributable To Company |
Effective Income Tax Rate(2) |
Diluted Earnings Per Share |
|||||||||||||||
As Reported GAAP |
$ |
1,637 |
$ |
419 |
$ |
1,218 |
|
$ |
1,146 |
|
25.6 |
% |
$ |
1.33 |
|
||||||
Global Growth and Efficiency Program |
|
71 |
|
18 |
|
53 |
|
|
53 |
|
— |
% |
|
0.06 |
|
||||||
Non-GAAP |
$ |
1,708 |
$ |
437 |
$ |
1,271 |
|
$ |
1,199 |
|
25.6 |
% |
$ |
1.39 |
|
The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
Notes:
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200731005085/en/
Source: